Exodus Point Capital Management, LP Kymera Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 14,126 shares of KYMR stock, worth $469,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,126Holding current value
$469,124% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding KYMR
# of Institutions
186Shares Held
65.6MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$228 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$199 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$176 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$171 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$171 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.82B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...